archive for Innovation
Frozen – not sunny side up! (position paper on egg freezing in Singapore – BELRIS)
Interesting article (click link) in The Singapore Straits Times today on a topic of increasing relevance to Singaporeans as they grapple with demographic challenges with respect to native population maintenance. With advanced economic development and increasing work-place participation of women, birth rates have been falling steadily and are now below natural population replacement rates causing [...]
Getting Pharma Off the Sidelines and Into the Big Data Game
This insightful article was provided to us by one of our contributors James J. Gillespie, President, Center for Healthcare Innovation and Brian Speicher, MBA Candidate, Sloan School of Management, MIT. “To a great extent, we have lost control of the data and, in many ways, our traditional position as information providers. Patients and others now [...]
Health Information Exchanges and the Power of Networking (part 1)
Last week I attended a Health Informatics conference in KL. Although I met some interesting people which happened to be my primary purpose anyway, not much else of significance was learned from the conference. Well-intentioned bureaucrats describing the desperate needs to connect Health care across the delivery spectrum and how they have struggled to build [...]
What’s the Next Model for Pharmaceutical Sales?
We all know smaller sales forces are here to stay, rather than a passing fad or purely a function of the deep global recession. Everyone recognizes that the old pharma sales rep model is dead and has been dying for some time now. In some sense, from the perspective of being induced to undergo transformative [...]
Asia relevant trends in Customer Relationship Management & the Pharma Industry
There is no doubt that the competitive landscape for CRM in the life sciences industries has entered a new phase in the US and Europe, but the same is no less true in Asia. CRM is increasingly becoming the leading driver of technology strategy and spend in this rapidly evolving landscape. As large pharmaceuticals increasingly [...]
Health care and Social Networking: Hey Doc, are you feeling social?
Last week I finally managed to squeeze in a chilled out evening at the movies into my busy social schedule (managed by my wife, Harman). The Social Network, a fascinating view into the maniacally hyper-exponential growth of Facebook launched just 6 years ago in 2004; from embryo to apparently over 500 million users as of July of 2010, under the inspiration and guidance of Mark Zuckerburg, who joined us on planet Earth in 1984…do the math: age 26.
New tactics in Asia: Surgical strikes and minimal collateral damage: Tremendous growth prospects in Asia’s Minimally Invasive Surgery Market
Minimally Invasive Surgery (MIS) procedure volumes in Asia have been growing at rapid rates in recent years. Developing economies are aggressively building the capabilities to conduct MIS while developed economies are investing in their depth of expertise to perform advanced procedures with cutting edge technology and devices. MIS device manufacturers should pay specific attention to [...]
The ABCs of UBCs (Umbilical Cord Blood Cells-Should you bank ‘em?)
On Monday, October 4, the Nobel committee at the Karolinska Institute in Sweden awarded the 2010 Prize for Physiology or Medicine to 85-year-old British physician Dr. Robert G. Edwards for the development of techniques that led to in vitro fertilization (IVF). His clinical work resulted in the first IVF birth of Louise Brown on July [...]
Little red riding hood (society) and the big bad wolf (branded pharma)
Those who know me well, know that I have a passion for economics and finance and without fail, I compliantly take my daily dose (nice medical metaphor!) of financial news and bloggers. One of the financial blogs I follow and mostly respect, is called “Naked Capitalism” which is founded and managed by Yves Smith. Well [...]
